Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lipozene is a commercial-stage consumer healthcare brand focused on weight management supplements. The product's primary active ingredient is glucomannan, a water-soluble dietary fiber derived from the konjac root (Amorphophallus konjac). Marketed by the Obesity Research Institute, LLC, Lipozene is sold as an over-the-counter dietary supplement intended to promote feelings of fullness and support weight loss. The company relies heavily on direct-to-consumer advertising and retail distribution. While widely available, the brand has historically faced regulatory scrutiny regarding the substantiation of its weight loss claims.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lipozene.